Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc"
Results 161 - 180
of 219
Sort by Relevance
|
Sort by Date
8 Feb 2011, 11:47 am
Merrill Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
30 Jan 2011, 5:29 pm
Merrell Dow Pharms., Inc., 43 F.3d 1311, 1315 (9th Cir.1995) (“ Daubert II ”). [read post]
27 Jan 2011, 5:14 pm
Citing the decision in Daubert v. [read post]
25 Jan 2011, 10:06 am
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993). [read post]
1 Dec 2010, 11:02 am
Merrell Dow Pharmaceuticals set the standard regarding the admissibility of expert witness testimony in federal court. [read post]
21 Nov 2010, 12:10 pm
Merrell Dow Pharmaceuticals, Inc., 959 F.2d 1349 (6th Cir.) [read post]
26 Oct 2010, 4:30 am
Merrell Dow Pharmaceuticals, decided by the Supreme Court in 1993. [read post]
24 Aug 2010, 11:34 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), in which the Court instructed district courts to function as gatekeepers and permit only reliable and relevant expert testimony to be presented to the jury. [read post]
4 Aug 2010, 7:57 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) established the test federal (and many state) judges currently use to determine the admissibility of expert testimony in trials and other proceedings. [read post]
17 Jul 2010, 10:13 pm
For example, an Arizona jury awarded a homeowner and his family more than $4 million for a case where the insurance carrier delayed remediating mold contamination (Hatley v. [read post]
8 Jul 2010, 3:30 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
4 Jul 2010, 4:16 pm
Merrell Dow Pharmaceuticals, Inc., 509 US 579 which, in federal courts, displaced the Frye general acceptance standard based upon the Federal Rules of Evidence. [read post]
23 Jun 2010, 3:35 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S. [read post]
27 May 2010, 3:40 pm
”Merrell Dow Pharmaceuticals, Inc. v. [read post]
6 May 2010, 4:12 pm
Metabolife International, Inc., 401 F.3d 1233, 1247 (11th Cir. 2005); Goebel v. [read post]
5 Apr 2010, 1:01 pm
Dow Merrell Pharmaceuticals, Inc., which prohibit the use of inaccurate, nonspecific tests and/or conclusory reports because they do not prove the presence of marijuana in a seized substance. [read post]
22 Mar 2010, 4:13 am
Merrell Dow Pharmaceuticals, Inc., 43 F.3d 1311, 1320 (9th Cir.), cert denied, 516 U.S. 869 (1995); see also In re W.R. [read post]
31 Dec 2009, 2:34 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and its federal and state progeny. [read post]
22 Dec 2009, 8:57 pm
Digital Sys., Inc. v. [read post]
18 Dec 2009, 11:57 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]